Internal Compartment Knee Osteoarthritis: ODRA (Orthosis Distraction and Rotation for osteoArthritis) Made-to-measure Hinged Knee Brace Versus Usual Care.
ERGONOMIE
Randomized Controlled Trial in Internal Compartment Knee Osteoarthritis: ODRA Made-to-measure Hinged Knee Brace Versus Usual Care.
1 other identifier
interventional
120
1 country
1
Brief Summary
This is a biomedical study on a medical device. 120 patients will participate in this study and will be split into 2 groups:
- 60 patients in the "usual care" group: these patients will receive the usual care proposed by their doctor for 12 months.
- 60 patients in the "ODRA" group: these patients will wear the ODRA brace for 12 months in addition to their usual care. They will be instructed to wear the brace for at least 6 hours per day, 5 days per week and to take it off during rest periods when lying down. The distribution of patients in the groups will be randomized. For this study, patients will be followed for 12 months, spread over 3 visits: inclusion visit, follow-up visit at 6 months and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 29, 2016
CompletedFirst Posted
Study publicly available on registry
May 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedAugust 22, 2018
August 1, 2018
2.4 years
April 29, 2016
August 20, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Pain measured using a VAS (visual analogue scale) by the patient
12 months
Secondary Outcomes (8)
Ratio differential cost-utility
12 months
Evolution of pain measured by VAS in the form of a self-questionnaire
6 months
Evolution of the Function score- Everyday life of the KOOS (Knee injury and osteoarthritis outcome score) self-questionnaire
12 months
Evolution of quality of life measured by the AMIQUAL self-questionnaire
12 months
Evolution de overall disease activity measured by VAS
12 months
- +3 more secondary outcomes
Study Arms (2)
ODRA
EXPERIMENTALusual care
ACTIVE COMPARATORInterventions
Port of the orthosis ODRA during day during 12 months, Complement to their usual care. The subjects will have for instruction to wear the brace a minimum of 6 hours a day, 5 days a week, And to remove it during the rest periods in lengthened position.
The patients will benefit only from the coverage proposed usually, by their regular doctor and according to the notices of the medical and paramedical specialists taking care of this pathology (physiotherapists, orthopaedic osteopaths, sports medicine physician, surgeon, rheumatologists, rehabilitative doctors, etc.). In the absence of recommendations on the modalities of coverage of the gonarthrose and in front of diverse clinical habits, the "usual" said coverage can be at the same time medicinal (anti-inflammatory, painkilling, …), non-medicinal (physiotherapy, port of an orthosis, …), even surgical, according to the influencers.
Eligibility Criteria
You may qualify if:
- Age ≥ 18
- Knee osteoarthritis (defined according to American College of Reumatology criteria):
- radiological stage II, III or IV according to the Kellgren and Lawrence (KL) classification documented by a radiological examination in the previous 12 months.
- Predominantly affecting the internal compartment (internal KL stage greater than external KL stage) and symptomatic with a Pain Visual Analogue Scale \> 40/100 on the target side (side with the most symptomatic disease)
- Patients who have provided written consent
- Patients able to understand simple instructions, to read, write, and to give informed consent
- Patients with national health insurance cover
You may not qualify if:
- Severe venous insufficiency in the lower limbs
- History of deep venous thrombosis in the lower limbs
- Inflammatory flare of knee osteoarthritis (synovial effusion) on the target side
- Person over 18 under guardianship or unable to provide consent
- Pregnant or breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Dijon Bourgogne
Dijon, 21079, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2016
First Posted
May 9, 2016
Study Start
February 1, 2015
Primary Completion
July 1, 2017
Last Updated
August 22, 2018
Record last verified: 2018-08